Guobang Pharma Ltd.

SSE:605507.SS

20.53 (CNY) • At close June 9, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q22020 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 1,586.2751,909.3171,475.051,341.3222,038.942,094.1592,116.2652,097.2092,560.8671,973.9921,913.8441,630.492910.106893.0061,657.584846.2991,017.2791,234.6031,086.768-1,264.684
Short Term Investments 746.174617.664685.68525.884342.395465.987271.737374.596594.461824.5599508501,202.4731,258.2571,100-2.796-3.0830.035131.4622,529.368
Cash and Short Term Investments 2,332.4492,526.9812,160.731,867.2062,381.3352,560.1462,388.0022,471.8053,155.3282,798.552,863.8442,480.4922,112.582,151.2642,757.584846.2991,017.2791,234.6381,218.231,264.684
Net Receivables 1,572.36101,368.3181,241.8121,006.0861,021.97900.145863.906789.278775.341724.842711.995691.63571.499519.12622.827713.703544.513551.8350
Inventory 1,439.7381,363.4111,307.0661,335.9051,463.1461,368.5571,336.0941,381.1661,463.8321,409.2041,417.9641,503.8171,408.7041,309.3291,218.7681,084.4811,028.69989.545862.2890
Other Current Assets 916.6631,983.907823.734668.209570.433492.474505.369427.857263.353146.223188.59455.814424.30941.106396.571131.49931.502102.47166.4880
Total Current Assets 6,261.2115,874.35,659.8495,113.1335,420.9995,443.1475,129.615,144.7345,671.7925,129.3195,195.245,152.1184,637.2224,567.2984,892.0432,685.1062,791.1742,871.1672,665.9011,264.684
Non-Current Assets:
Property, Plant & Equipment, Net 4,290.354,343.6574,401.1344,391.3884,383.4144,330.0444,076.3853,902.5063,462.4983,283.5163,026.9342,885.3312,742.6482,621.9642,270.1532,238.0522,236.1482,152.0981,692.6350
Goodwill 0.0250.0250.0250.0250.0250.0250.0250.0250.0250.0250.0250.0250.0250.0250.0250.0250.0250.0250.0250
Intangible Assets 348.344350.835353.845354.631356.238358.847362.023365.006369.107370.496376.495273.402270.267272.265274.082262.726264.484266.706271.540
Goodwill and Intangible Assets 348.37350.86353.87354.656356.264358.873362.048365.031369.132370.522376.521273.427270.293272.29274.108262.752264.51266.732271.5660
Long Term Investments -635.559-505.09-565.856194.223-221.964-344.86-171.9-263.516-493.532-723.192-918.76-818.674-1,170.865-1,241.145-1,082.44920.87321.56418.638-111.8940
Tax Assets 8.7428.967.00510.05816.9657.77814.3695.8316.1976.58620.02318.50418.90119.01712.28112.19512.9912.01113.1380
Other Non-Current Assets 841.57707.75777.38523.503445.085566.653368.894496.367752.386976.4331,060.136952.781,260.9581,273.6481,344.853214.494198.249187.929375.546-1,264.684
Total Non-Current Assets 4,853.4734,906.1364,973.5384,973.8284,979.7634,918.4884,649.7964,506.2184,106.683,913.8653,564.8543,311.3683,121.9352,945.7742,818.9462,748.3662,733.4612,637.4082,240.99-1,264.684
Total Assets 11,114.68410,780.43610,633.38710,086.96110,400.76310,361.6359,779.4069,650.9529,778.4729,043.1858,760.0958,463.4867,759.1577,513.0727,710.9895,433.4735,524.6355,508.5754,906.8920
Liabilities & Equity:
Current Liabilities:
Account Payables 1,592.3031,703.6741,652.153492.3811,507.0581,714.6121,343.3391,182.2461,426.564974.347794.216897.298810.624789.707743.817780.7661,103.0171,095.742792.4680
Short Term Debt 373.145175.134325.229845.482353.001482.694501.22549.175685.946655.57755.571615.505190.202160.16675.457524.573408.535509.407432.2640
Tax Payables 42.63449.88751.68423.3830.18534.22719.59917.72416.23917.98944.16548.34762.38743.31217.07836.65743.82334.65248.0660
Deferred Revenue 00050.812176.626218.813208.843202.78656.08352.79152.72600200.389159.786141.546193.658214.062217.2030
Other Current Liabilities 483.962629.092533.758899.164-25.911162.24-16.444291.6145.434214.476144.265161.709136.403129.65102.517220.49554.42332.889249.1840
Total Current Liabilities 2,492.0442,557.7872,562.8242,260.4072,175.0042,449.6222,056.5572,068.9622,392.9211,862.3821,790.9421,722.8591,199.6161,153.511,258.4411,562.4911,803.4521,972.4651,521.9820
Non-Current Liabilities:
Long Term Debt 337.371146.721203.711230.027584.807451.7381.999381.97300000002062512514150
Deferred Revenue Non-Current 18.19216.67413.60813.92611.19211.812.41213.12813.73314.26711.2829.0969.4019.7089.40410.168.0138.2728.7910
Deferred Tax Liabilities Non-Current 7.8017.1977.3856.64521.04911.32521.47210.72222.24211.9312.5312.5534.1394.1612.6192.6412.6632.693.0050
Other Non-Current Liabilities 00013.9260000000000000048.1650
Total Non-Current Liabilities 363.364170.592224.704236.672617.047474.825415.883405.82335.97426.19813.81311.64913.5413.86912.023218.801261.676261.962474.9610
Total Liabilities 2,855.4082,728.3792,787.5282,497.0792,792.0512,924.4472,472.4392,474.7852,428.8951,888.581,804.7551,734.5081,213.1561,167.3791,270.4641,781.2932,065.1282,234.4271,996.9430
Equity:
Preferred Stock 00000000000000000000
Common Stock 558.824558.824558.824558.824558.824558.824558.824558.824558.824558.824558.824558.824558.824558.824558.8244754754754750
Retained Earnings 3,883.2793,668.3023,494.5213,320.2343,281.0223,082.293,000.2682,868.6653,041.1182,846.4882,664.5712,438.5452,255.6662,055.2712,249.0862,105.6931,913.1031,728.0031,369.8310
Accumulated Other Comprehensive Income/Loss 003,788.506183.8313,790.92183.8313,749.944142.4633,749.9443,749.9443,732.022124.5413,731.985124.5413,632.63500-002,616.733
Other Total Stockholders Equity 3,813.1743,820.215-1.4793,507.562-27.5863,790.9203,749.94403,749.94403,732.02203,731.98501,071.731,071.731,071.731,066.527-0.873
Total Shareholders Equity 8,255.2778,047.347,840.3717,570.457,603.1797,432.0347,309.0357,177.4337,349.8867,155.2566,955.4176,729.3916,546.4746,346.0796,440.5443,652.4243,459.8333,274.7332,911.3572,615.859
Total Equity 8,259.2768,052.0577,845.8597,575.9567,608.7127,437.1897,306.9677,176.1677,349.5767,154.6056,955.3396,728.9786,5466,345.6946,440.5253,652.183,459.5073,274.1482,909.9492,615.859
Total Liabilities & Shareholders Equity 11,114.68410,780.43610,633.38710,086.96110,400.76310,361.6359,779.4069,650.9529,778.4729,043.1858,760.0958,463.4867,759.1577,513.0727,710.9895,433.4735,524.6355,508.5754,906.8922,615.859